No Business as Usual: Challenging the IP Protection Framework Now and After COVID-19

139 Aufrufe

  • Danke für die Bewertung! Teile es mit Deinen Freunden!

    Danke für Deine Bewertung!

admin
Published
The COVID-19 pandemic has posed many challenges to governments attempting to protect their citizens and ensure access to vaccines, therapeutics, and other health goods. While in the early stages of the pandemic some governments, and the European Commission, pledged collaboration to make vaccines global public goods, reality has evolved in a different direction. We have witnessed wealthier countries engaging in vaccine hoarding, with the challenge this poses exacerbated by manufacturers unable to meet global demand yet resisting all calls to share know-how or collaborate in scaling-up production. The symptoms of this are clear, but what are the remedies? Find out more in this recording of a webinar hosted by Health Action International on 17 March 2021.

Moderator:
- Nicoletta Dentico, Head of Global Health Programme, Society for International Development

Panellists:

- Tilly Metz, Member of the European Parliament, Greens/EFA
- K.M. Gopakumar, Policy Advisor, Third World Network
- Dr. Geraldo Vidigal, International Law Professor, University of Amsterdam
- Julie Steendam, Campaign Coordinator, Right2Cure
Kategorien
Corona Virus aktuelle Videos
Kommentare deaktiviert.

Als nächstes

Яндекс.Метрика Top.Mail.Ru